Author:
Nielsen O. H.,Seidelin J. B.,Munck L. K.,Rogler G.
Reference129 articles.
1. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn’s and Colitis Organization: When to Start, When to Stop, Which Drug to Choose, and How to Predict Response?;D’Haens;Am J Gastroenterol,2011
2. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn’s disease: results from the CHARM study;Feagan;Gastroenterology,2008
3. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease;Rutgeerts;Gastroenterology,2004
4. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab;Sandborn;Gastroenterology,2009
5. The pharmacoeconomics of biologic therapy for IBD;Cohen;Nat Rev Gastroenterol Hepatol,2010
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献